✦ LIBER ✦

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

✍ Scribed by Brose, Marcia S; Nutting, Christopher M; Jarzab, Barbara; Elisei, Rossella; Siena, Salvatore; Bastholt, Lars; de la Fouchardiere, Christelle; Pacini, Furio; Paschke, Ralf; Shong, Young Kee; Sherman, Steven I; Smit, Johannes W A; Chung, John; Kappeler, Christian; Peña, Carol; Molnár, István; Schlumberger, Martin J

Book ID: 121740737
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 367 KB
Volume: 384
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(14)60421-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vandetanib in locally advanced or metast

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

✍ Sophie Leboulleux; Lars Bastholt; Thomas Krause; Christelle de la Fouchardiere; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 324 KB

Docetaxel and dasatinib or placebo in me

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

✍ Araujo, John C; Trudel, Géralyn C; Saad, Fred; Armstrong, Andrew J; Yu, Evan Y; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 703 KB

Gefitinib versus placebo as maintenance

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

✍ Li Zhang; Shenglin Ma; Xiangqun Song; Baohui Han; Ying Cheng; Cheng Huang; Shuju 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 371 KB

257 Design of RESILIENCE: a Phase 3 TRia

257 Design of RESILIENCE: a Phase 3 TRial Comparing CapecitabinE in Combination with SorafenIb or PLacebo for Treatment of Locally Advanced or MetastatIc HER2-Negative Breast CancEr

✍ J. Baselga; F. Costa; H. Gomez; C. Hudis; B. Rapoport; H. Roche; L.S. Schwartzbe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase 3 tRial comparing capecitabinE i

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

✍ José Baselga, Frederico Costa, Henry Gomez, Clifford A Hudis, Bernardo Rapoport… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 246 KB

Fulvestrant plus anastrozole or placebo

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

✍ Johnston, Stephen RD; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, Dav 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 459 KB